Human Immunodeficiency Virus Type-1 Reverse Transcriptase
Open Access
- 1 June 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (23), 13656-13662
- https://doi.org/10.1074/jbc.271.23.13656
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1993
- The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1993
- Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.Proceedings of the National Academy of Sciences, 1993
- Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosidesAntimicrobial Agents and Chemotherapy, 1993
- Mutational analysis of two conserved sequence motifs in HIV‐1 reverse transcriptaseFEBS Letters, 1991
- HIV-1 Reverse Transcriptase: Structure Predictions for the Polymerase DomainAIDS Research and Human Retroviruses, 1990
- Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.Proceedings of the National Academy of Sciences, 1989
- A sequence motif in many polymerasesNucleic Acids Research, 1988
- Site-specific mutagenesis of AIDS virus reverse transcriptaseNature, 1987
- Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial virusesNucleic Acids Research, 1984